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Disrupted circadian rhythms and sleep patterns are frequently observed features of
psychiatric disorders, and especially mood disorders. Sleep deprivation treatment (SD)
exerts rapid but transient antidepressant effects in depressed patients and has gained
recognition as a model to study quick-acting antidepressant effects. It is of interest how
locomotor activity patterns during SD might be associated with and potentially predict
treatment response. The present study is an analysis of locomotor activity data, previously
collected over a 24 h period, to examine the night of SD (Trautmann et al. 2018) as mood
disorder patients suffering from a depressive episode (n = 78; after exclusions n = 59)
underwent SD. In this exploratory analysis, the associations between response to SD,
locomotor activity, and subjective mood during the 24 h period of SD were explored.
Higher levels of activity overall were observed in non-responders (n = 18); in particular,
non-responders moved more during the evening of SD until midnight and remained high
thereafter. In contrast, activity in responders (n = 41) decreased during the evening and
increased in the morning. Subjective mood was not found to be associated with
locomotor activity. The window of data available in this analysis being limited, additional
data from before and after the intervention are required to fully characterize the results
observed. The present results hint at the possible utility of locomotor activity as a predictor
and early indicator of treatment response, and suggest that the relationship between SD
and locomotor activity patterns should be further investigated.
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Disruption of sleep and circadian rhythms are often reported
as features of psychiatric disorders, and chronotherapeutic
treatments targeting the circadian system have shown the ability
to affect disease symptoms (1–5). Therapeutic sleep deprivation
(SD), involving a night without sleep, is one such treatment which
has been found to rapidly induce an antidepressant response in
depressed patients. Interestingly, this effect is transient with
depressive symptoms reappearing directly after recovery sleep
(6–10). While response to pharmacological antidepressants often
takes weeks to emerge, SD can be quickly administered in a
controlled fashion, providing an efficient model to study fast-
acting antidepressants. SD Response is thought to be associated
with various factors; several hypotheses about mechanisms of
action have been proposed (11–14), with a popular one
suggesting that SD acts through resetting circadian processes
which are dysregulated in depression (15–19).
Altered psychomotor behavior has been found to be
associated with many psychiatric disorders and disrupted
circadian rhythmicity observed in affective disorders can also
be reflected in locomotor activity patterns (20–29). While there is
evidence suggesting that better mood is correlated with
increased (everyday/non-exercise) locomotor activity (30–34),
it is becoming apparent that the relationship between locomotor
activity with psychiatric disorders is complex. For example, a
pedigree study examining genetic contributions to circadian
rhythms segregating by bipolar disorder (BD) severity showed
that BD individuals consistently demonstrated lower levels of
activity than their non-BD relatives (35). Studies in unrelated
patients showed that mania patients display more complex
activity patterns in the active morning period compared to
depressed patients (36). Meanwhile, compared to healthy
controls, individuals suffering from depression display lower
mean activity levels (27, 36, 37) but higher variability over the
whole day as well as in the active morning period (36). The
characterization of these relationships is becoming increasingly
feasible thanks to recent developments in wearable and
mobile sensing technologies, especially in easy and non-invasive
monitoring of locomotor activity (38–40) using wristwatch-type
actigraph, making it a promising method which can be
implemented with high compliance in clinical contexts.
It is of interest to explore how locomotor activity of patients
changes through SD and whether this change is associated with
response. Various actigraphy studies have been carried out in
depressed populations (21–23, 30, 40, 41) but only a few studies
in the SD context have assessed aspects of locomotor activity
during treatment, and those in limited samples (18, 42–45). One
study found that several manic-depressive patients emerging
from depressive phases advanced awakening times, and in a
depressed patient, that moving forward the sleep-wake cycle
had an antidepressant effect (42). Another study investigated
the effects of partial SD (PSD) on motor activity, finding that
at baseline, responders moved more than non-responders and
that all subjects increased activity following PSD (18). One other
study, which used ethological methods to assess activation inFrontiers in Psychiatry | www.frontiersin.org 2a pre-SD interview, found the amount of “looking at the
interviewer” to be negatively correlated with response to
treatment, while observing a positive correlation between
“body and object-touching hand movements” and SD response
(43). More recently, a study using repeated SD and light therapy
in 39 bipolar patients experiencing depressive episodes observed
that responders showed increases in activity during the day, and
advance in phase of activity-rest rhythms as well as reduced sleep
at night after SD, while in contrast, non-responders showed no
such changes (44). Another recent paper on 34 patients with
major depression did not observe significant differences in
activity related to response on the day before SD; during the
night, compared to non-responders, responders had increased
activity and rested less, and were more active the day after
SD (45).
In a recent study, we examined the clinical and genetic factors
associated with SD response in a large SD sample (46). In this
naturalistic study, SD was conducted in 78 depressed major
mood disorder inpatients; 72% responded to SD. Responders and
non-responders differed in mood, but not in symptom severity or
chronotype. Response was also found to be associated with being
younger during SD treatment, and with higher age at time of
lifetime disease onset. Significantly higher polygenic risk scores
for depression were found in non-responders than healthy
controls, while responders had intermediate risk scores.
In the present exploratory secondary analysis, we examined
the relationship between SD response and locomotor activity
which had been acquired during SD treatment in the same
sample (46). Locomotor activity and measurements of
subjective mood had been acquired over the course of 1 day as
patients underwent SD therapy. Given the equivocal nature of
previous reports of locomotor activity in responders and
non-responders during SD, we compared the trajectories of
locomotor activity in responders vs. non-responders. The
relationship between locomotor activity and subjective mood
was also examined.METHODS
Participants
The cohort studied here has been previously described in (46).
As an exploratory secondary analysis, we examined locomotor
activity data acquired during SD in the same sample. Seventy-
eight mood disorder inpatients (34F; age in years mean ± std.
dev. = 43.54 ± 14.80, major depressive disorder, n = 71; BD I,
n = 6; and BD II, n = 1) experiencing major depressive episodes
(ICD-10) were recruited from consecutive admissions to
the depression unit of the Department of Psychiatry and
Psychotherapy of the Central Institute of Mental Health
(CIMH, Mannheim, Germany). Patients had to have been on
stable medication regimens for 5+ days prior to undergoing SD.
The study was approved by the CIMH ethics committee (II).
After being given an explanation of the study, all participants
gave written informed consent.July 2020 | Volume 11 | Article 688
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Baseline variables were assessed on Day 1 (Figure 1). Patients
engaged in regular ward activities in the daytime on Day 2. In the
evening on Day 2, small groups (1–5 patients) underwent staff-
supervised SD. Participants stayed awake for ~36 h from 6:00 am
(Day 2) to 6:00 pm (Day 3). On Day 3, patients returned to




The senior clinical researcher (MD) assessed response to SD
using the seven-point Clinical Global Impression Scale of Global
Improvement or Change (CGIC) (47) between 4:00 and 5:00pm
on Day 3. In the CGIC, the clinician assesses improvement or
worsening of the illness relative to before the intervention.
Response was dichotomized: response was defined as scores of
≤2 (1: very much improved; 2: much improved) and non-Frontiers in Psychiatry | www.frontiersin.org 3response was define as scores ≥3 (3: minimally improved;
4: No change; 5: Minimally worse; 6: Much worse; 7: very
much worse).
Locomotor Activity
The SOMNOwatch (SOMNOmedics GmbH, Germany), a wrist-
worn actigraph equipped with three activity sensors (x, y, z-axis),
from which acceleration data are stored (magnitude, calculated
as the square root of x2 + y2 + z2), was used to assess locomotor
activity. The range of measurement of the SOMNOwatch is ±8.7
G, and the device has a sensitivity of 0.004 G. Activity was
sampled at 60 Hz and stored every 60 s. The devices were worn
from 5:00 pm on Day 2 to 6:00 pm on Day 3 (i.e. until recovery
sleep, a total of 1,500 min). Patients had been instructed to wear
actigraphs at all times except for when they were in the shower or
engaging in exercise.
Participants were asked to record if they removed the devices on
a wear log. Data were transferred to computer via USB connection.FIGURE 1 | Experimental timeline and sample subjective mood and locomotor data (mg) for a responder and non-responder over the course of sleep deprivation
treatment (thicker bar). Response was evaluated between 1600 and 1700 h on Day 3. Dark blue bar denotes time during which locomotor activity was recorded.July 2020 | Volume 11 | Article 688
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Subjective Mood
Participants completed a VAS (48) assessing subjective mood
(hereafter referred to as “mood”) at 2-h intervals from 10:00 am
on Day 2 to 6:00 pm on Day 3. Possible ratings ranged from
“worst mood imaginable (0)” to “best mood imaginable (10)”;
patients indicated their mood in 0.5 point increments. Our
previously reported study observed that mood was better in
responders than non-responders (46).
Data Analysis
IBM SPSS Statistics for Windows (v. 25) was used to perform
statistical analyses. An alpha of 0.05 was used as the threshold for
statistical significance.
Locomotor activity data were preprocessed prior to
analysis. Four subjects who were excluded in the previous
study for napping were also excluded in the present analysis.
No locomotor data was available for five individuals, whose data
were excluded from the analysis. Individual data traces were
visually inspected. Furthermore, data from patients (n = 7) who
had more than 60 consecutive minutes of no activity detected
during the recording period were excluded (potentially
indicating that they had removed the devices, and perhaps had
forgotten to wear them again for a period of time). It was decided
that 60 min would be used as a reasonable allowance of time for a
patient to engage in exercise or taking a shower.
Mean locomotor activity was calculated for a window of 60
min around (i.e. +/−30 min) VAS mood assessments, as in (31),
hereafter referred to as “locomotor activity.” A total of 12 mood
assessments (every 2 h from Day 2 at 6:00 pm to Day 3 at 4:00
pm) from each subject were included to match the window
recorded locomotor activity. Three subjects for whom no
mood data were available were excluded from analysis, giving
59 patients who entered the final analysis, comprising 691
matched mood (a few participants did not indicate mood for
several time points) and locomotor activity values. It should
be noted that while the total sample was the same as in (46),
there were differences in the data available, for example, in
the present analysis, patients without locomotor data were
excluded, but included in the previous study as they had
genetic data.
To explore relationships between response to SD, locomotor
activity, and mood, linear mixed models were employed (49).
Models with random intercepts and random or fixed slopes for
within-subject variables were estimated using maximum
likelihood estimation, using a stepwise approach, and the
goodness-of-fit of models was compared by using the deviance
test on -2 log likelihood. Akaike’s Information Criterion (AIC)
was also examined and agreed with the results of the deviance
test. Non-significant random effects were not included in
the model, and where models did not differ significantly, the
more parsimonious model (with fewer effects) was chosen. The
resulting main model was specified as follows. Locomotor
activity was specified as the dependent variable. Response
(response/non-response) and sex (female/male) were included
as fixed factors. BMI, age, mood centered around subject mean,Frontiers in Psychiatry | www.frontiersin.org 4and mean subject mood were included as fixed continuous
variables. Time point and time point2 (to model a circadian
effect) were also included as fixed continuous variables. Time
point was also added as a random effect. Interactions between
Response x time point as well as response x time point2 were
specified as fixed effects. Time point variables were centered
to midnight. The intercept was included in the model as a
random effect.
To further examine associations of locomotor activity with
response to treatment and subjective mood at specific time
points, another model was specified with the same fixed factors
and continuous variables as the above main model, but with time
point included as a fixed categorical factor. Time point2 was
not included.RESULTS
Sixty-nine point five percent of patients (41/59) were evaluated to
be responders while 30.5% (18/59) were non-responders. The
main mixed model for mean locomotor activity (see Table 1)
revealed main effects of response, with non-responders moving
more than responders (t(66.856) = 2.570, p = 0.012). A significant
main effect of time point2 was observed, indicating a U-shaped curve
of activity (t(582.872) = 2.730, p = 0.007). A significant main effect






Intercept 179.927 27.4765 59.003 6.549 .000
Non-Responder 29.099 11.323 66.856 2.570 .012
Responder a
Female -6.508 9.609 58.745 -.677 .501
Male a
Age -1.014 .353 58.621 -2.874 .006
Body Mass Index -.474 .796 58.655 -.595 .554
Mean Subject Mood 4.311 3.038 58.728 1.419 .161
Centered Subject Mood -1.079 1.451 591.884 -.744 .457
Time Point -.792 1.487 213.188 -.532 .595
Time Point2 .590 .216 582.872 2.730 .007
Non-response * Time Point -.133 2.686 212.016 -.049 .961
Response* Time Point a
Non-response * Time Point2 -.468 .396 593.034 -1.183 .237







Residual 2469.881 145.813 16.939 .000
Intercept [subject = ID] Variance 1024.446 240.514 4.259 .000
Time Point [subject = ID] Variance 25.803 8.412 3.068 .002July 2020 | Volume 11 | Article 6Mean locomotor activity (mg) 60 minutes around mood assessments (+/- 30 mins) was
specified as the dependent variable. Significant (p < 0.05) associations are indicated in
bold.
aReference.88
Foo et al. Movement in Sleep Deprivation Treatmentlocomotor activity (t(58.621) = −2.874, p = 0.006). No significant
effects of subject mean-centered mood,mean subject mood, sex, BMI,
and time point were observed (all p > 0.05). A significant random
effect of time point was observed (p = 0.02), revealing variability
between subjects in the within-subject relationship between time
point and locomotor activity. To examine whether diagnosis of
bipolar disorder influenced results, the analysis was repeated with a
variable differentiating between unipolar/bipolar depression—no
significant differences were observed and the variable was not
included in the analysis.
The model calculated using time point specified as a discrete
variable observed only a significant main effect of age (t(58.222) =
−2.750, p = 0.008); no other fixed effects were significant. The
interaction term between response x time point revealed higher
locomotor activity levels in non-responders the evening of SD (i.e.
2000 h t(632.876) = 2.178, p = 0.030; 2200 h t(632.873) = 2.046,
p = 0.041; 2400 h t(632.871) = 2.028, p = 0.043). Figure 2
shows trajectories of locomotor activity for responders and
non-responders.
Next, a post-hoc analysis was used to examine whether
locomotor activity and mood might be differentially correlated
between responders and non-responders. The same model as
above was used, stratifying by response status. Mood trajectory
(subject centered mood) was not significantly associated with
locomotor activity in responders (t(440.277) = −1.057, p = 0.291)
or non-responders (t(190.845) = 0.882, p = 0.379).
In responders, a significant main effect of time point2 (t
(440,710) = 2.559, p = 0.011) and no significant effects of
mean subject mood, sex, time point, age, and BMI wereFrontiers in Psychiatry | www.frontiersin.org 5observed. In non-responders, a significant main effect of age (t
(17.637) = −2.885, p = 0.010) and no significant effects of time
point, time point2,mean subject mood, sex, and BMI (all p > 0.05)
were observed.DISCUSSION
The present analysis examined locomotor activity throughout
a 24-h time period as depressed patients underwent SD.
We observed higher activity in non-responders compared to
responders throughout SD and the differences were most
pronounced during the evening of the day of SD until midnight.
Activity remained constantly high in non-responders while in
responders a dip in activity was observed, followed by an increase
over time; the post-hoc test stratified for response showed a
significant U-shaped curve in responders but not non-responders.
One interpretation of the present observations is that non-
responders have more severely disrupted rest-activity cycles.
Lower relative amplitude, or difference between activity in
active and rest periods, as assessed via actigraphy, has been
associated with higher risk for mental health issues and poorer
subjective wellbeing (20). It has also been observed that
compared to healthy controls, depressed patients have lower
activity levels during the day time but higher activity levels at
night (23). It is possible that the circadian activity of responders
is closer to that of healthy controls, while non-responders may
have more disrupted circadian rhythms, thus showing decreased
amplitude. Indeed, our findings are in line with a study observingFIGURE 2 | Locomotor activity trajectories for Responders (n = 41) and Non-Responders (n = 18). Figure is drawn based on estimated marginal means calculated
in mixed model with time specified as a discrete variable. Error bars denote standard error of mean. *p < 0.05.July 2020 | Volume 11 | Article 688
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non-responders did not (44); blunting of circadian amplitude is
suggested to be the main chronobiological abnormality in
depression (50).
Unfortunately, many prior SD studies are not directly
comparable, as they have used e.g., differing SD regimens (18, 44),
actigraphy assessments (see below) and/or different definitions of
response (compared to ours and each other). The present findings
offer a different perspective from (18), who observed that responders
showed higher locomotor activity pre-SD, however, they reported
activity during the day and did not record in the late evening, as well
as from (45), who reported that responders have higher activity than
non-responders during SD. While some studies define response as
% reduction in composite scores of ratings such as HAM-D (44, 45)
the CGIC (47) performed by experienced clinicians which is a
comparative rating well suited to assessing change was used in the
present study. As an analysis of pre-existing data, the present study
examined locomotor activity only during the SD regimen, in the
hospital environment, as opposed to during regular activity.
Although differences were observed in the evening before regular
sleep hours (i.e. still part of the patient’s “regular” circadian pattern),
further investigation outside of the SD protocol will be needed to
clarify movement patterns and their meaning.
Studies employing actigraphy in studying response to
pharmacological antidepressant treatments (largely using pre-
post designs) are also not yet conclusive as to their relationships
(51), with some studies observing no changes in motor activity
associated with treatment response (52) while others suggest that,
for example, the change in quantity of actigraphic movements
reflects change in depression psychopathology (53). That said, our
results might fit with a previous actigraphic pharmacological study
on treatment response, which reported that activity at treatment
onset and clinical improvement were negatively correlated, and
which observed a trend towards higher activity in nonresponders
than responders, and which suggested further exploration of this
difference as a predictor of treatment response (54).
It has been proposed that one use of actigraphy might be to
identify agitation in depression (23) and the present sample offers
an additional point to examine. In our previous report, depressive
symptom severity was assessed by clinician (Montgomery-Åsberg
Depression Rating Scale) (55) and patient (Beck Depression
Inventory-II, BDI-II, self-report version) (56), with consistent
significant correlations observed between the scales (46); no
differences were observed at baseline between responders and
non-responders. The BDI-II contains an item assessing the
symptom “agitation.” We conducted an additional post-hoc test
(one-way analysis of variance) to examine whether responders
and non-responders differed in BDI-II “agitation” scores, finding
that baseline (p = 0.698) and post-SD (p = 0.354) scores did not
differ between groups. This suggests that results did not reflect
differences in agitation (i.e. agitated depression), but it may also be
that this is a demonstration of an advantage that actigraphy, as an
objective measure, can add to classical assessment methods.
Mood is often positively correlated to locomotor activity in
the literature, but this was not found in the present results; this
may be explained by several factors. As shown in our previousFrontiers in Psychiatry | www.frontiersin.org 6work (46), subjective mood assessments do not necessarily reflect
the same changes as did the global clinical judgement of
response. Next, the present mood data were acquired in the
midst of the fatigue-inducing SD intervention whereas positive
mood-locomotor correlations are often observed in data
acquired during daily life. Furthermore, it is uncertain whether
mood improvements resulting from SD, changes in locomotor
activity, and their relationship, are linear processes with respect
both to magnitude and timing and it may also be that the present
dataset is too sparse to exhibit associations. Additional research
examining different dimensions of mood and assessing specific
factors (e.g. depressive symptoms) may help to clarify relationships
with locomotor activity.
Varying protocols and devices used so far make it difficult to
assess the interaction between locomotor activity and therapeutic
responsiveness (57), and this is a relevant factor in interpreting
the present findings in context to the literature. A detailed
description of different actigraphic methodologies is beyond the
scope of this article, and more detail can be found elsewhere (58–
60) (Table S1 provides an overview of actigraphic models used in
relevant studies).
Briefly, the digitally integrated magnitude vector acquired in
the present study is the most recently developed and yields a
more comprehensive measure of physical acceleration than other
methods (time-over threshold, zero-crossing), taking into
account the amplitude of movement. It is not that one method
is necessarily better than the others, but researchers should be
aware of the differences between devices as different types and
settings can produce very different amounts of activity when
recording the same thing (60).
There were several limitations to this study. First, given that
this was a naturalistic study and recruitment was done from
consecutive admissions, patients were not randomized or
stratified during recruitment. Second, the present analysis
explored a pre-existing dataset in which the recording period
was restricted, providing a useful but limited picture; future
research should monitor locomotor activity for extended
periods preceding (potentially informing patient screening)
and following SD (to examine effects of SD on rest-activity
patterns), allowing comparison with baseline and post
treatment activity. To better test the utility of locomotor
activity as a distinguishing feature which can predict response
and non-response, recording during a run-in baseline period will
be required. Next, while individual locomotor activity traces were
inspected carefully, it may not be possible to definitively
distinguish periods of time where participants may have been
briefly resting, from when they may have taken short naps, using
actigraphy alone. This issue requires further examination. It has
been observed that naps potentially disrupt a successful SD
response and can reverse antidepressant effects (61). While this
was not an issue during night-time supervised SD and during
ward activities the next day, we cannot exclude that brief naps
may have occurred in some of the patients, possibly leading to
early relapse to depression and thus potential misclassification of
responders as non-responders. However, given clinical protocols,
we believe that misclassification is unlikely—patients were seenJuly 2020 | Volume 11 | Article 688
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the afternoon. The CGI was assessed by a clinician very familiar
with the patient and also based on reports about SD response
from staff on the ward accompanying the patient throughout
the night.
Prior findings and those from the present study suggest to
further explore the correlation between locomotor activity and
mood and its potential role as a predictor of treatment response.
Availability and use of wearable and mobile sensing devices has
increased exponentially (38), and given the suitability of the
devices and the ambulatory assessment approach (62, 63) to
longitudinally study sleep and circadian disruptions, they should
be employed further to study psychopharmacologic effects (57).
We propose that application of such an approach, augmented
with the acquisition of additional physiological, biological, and
behavioral factors will go beyond the identification of predictors
and eventually lead to better understanding of mechanisms
behind not only fast-acting treatments such as SD, but of
disease mechanisms on a larger scale.DATA AVAILABILITY STATEMENT
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Wolters M. Activity monitoring in patients with depression: a systematic
review. J Affect Disord (2013) 145(1):21–8. doi: 10.1016/j.jad.2012.07.001
24. Indic P, Murray G, Maggini C, Amore M, Meschi T, Borghi L, et al. Multi-
scale motility amplitude associated with suicidal thoughts in major
depression. PloS One (2012) 7(6):e38761. doi: 10.1371/journal.pone.0038761
25. Walther S, Hugli S, Hofle O, Federspiel A, Horn H, Bracht T, et al. Frontal
white matter integrity is related to psychomotor retardation in major
depression. Neurobiol Dis (2012) 47(1):13–9. doi: 10.1016/j.nbd.2012.03.019
26. Volkers AC, Tulen JH, van den Broek WW, Bruijn JA, Passchier J,
Pepplinkhuizen L. Motor activity and autonomic cardiac functioning in
Variance. J Affect Disord (2003) 76(1-3):23–30. doi: 10.1016/s0165-0327(02)
00066-6
27. Berle JO, Hauge ER, Oedegaard KJ, Holsten F, Fasmer OB. Actigraphic
registration of motor activity reveals a more structured behavioural pattern
in schizophrenia than in major depression. BMC Res Notes (2010) 3:149. doi:
10.1186/1756-0500-3-149
28. Hallgren M, Herring MP, Owen N, Dunstan D, Ekblom O, Helgadottir B, et al.
Exercise, Physical Activity, and Sedentary Behavior in the Treatment of Depression:
Broadening the Scientific Perspectives and Clinical Opportunities. Front Psychiatry
(2016) 7:36. doi: 10.3389/fpsyt.2016.00036
29. Nakamura T, Kiyono K, Wendt H, Abry P, Yamamoto Y. Multiscale Analysis
of Intensive Longitudinal Biomedical Signals and Its Clinical Applications.
Proc IEEE (2016) 104(2):242–61. doi: 10.1109/JPROC.2015.2491979
30. Kim J, Nakamura T, Kikuchi H, Yoshiuchi K, Sasaki T, Yamamoto Y.
Covariation of depressive mood and spontaneous physical activity in major
depressive disorder: toward continuous monitoring of depressive mood. IEEE
J BioMed Health (2015) 19(4):1347–55. doi: 10.1109/JBHI.2015.2440764
31. Kim J, Nakamura T, Kikuchi H, Sasaki T, Yamamoto Y. Co-variation of
depressive mood and locomotor dynamics evaluated by ecological momentary
assessment in healthy humans. PloS One (2013) 8(9):e74979. doi: 10.1371/
journal.pone.0074979
32. Koch ED, Tost H, Braun U, Gan G, Giurgiu M, Reinhard I, et al. Mood
Dimensions Show Distinct Within-Subject Associations With Non-exercise
Activity in Adolescents: An Ambulatory Assessment Study. Front Psychol
(2018) 9:268. doi: 10.3389/fpsyg.2018.00268
33. Kanning MK, Ebner-Priemer UW, Schlicht WM. How to Investigate Within-
Subject Associations between Physical Activity and Momentary Affective
States in Everyday Life: A Position Statement Based on a Literature
Overview. Front Psychol (2013) 4:187. doi: 10.3389/fpsyg.2013.00187
34. Reichert M, Tost H, Reinhard I, Zipf A, Salize H-J, Meyer-Lindenberg A, et al.
Within-Subject Associations between Mood Dimensions and Non-exercise
Activity: An Ambulatory Assessment Approach Using Repeated Real-Time
and Objective Data. Front Psychol (2016) 7:918. doi: 10.3389/fpsyg.2016.00918
35. Pagani L, St Clair PA, Teshiba TM, Service SK, Fears SC, Araya C, et al.
Genetic contributions to circadian activity rhythm and sleep pattern
phenotypes in pedigrees segregating for severe bipolar disorder. Proc Natl
Acad Sci U.S.A. (2016) 113(6):E754–61. doi: 10.1073/pnas.1513525113Frontiers in Psychiatry | www.frontiersin.org 836. Krane-Gartiser K, Henriksen TE, Vaaler AE, Fasmer OB, Morken G.
Actigraphically assessed activity in unipolar depression: a comparison of
inpatients with and without motor retardation. J Clin Psychiatry (2015) 76
(9):1181–7. doi: 10.4088/JCP.14m09106
37. Gershon A, Ram N, Johnson SL, Harvey AG, Zeitzer JM. Daily Actigraphy
Profiles Distinguish Depressive and Interepisode States in Bipolar Disorder.
Clin Psychol Sci (2016) 4(4):641–50. doi: 10.1177/2167702615604613
38. Kumar S, Nilsen W, Pavel M, Srivastava M. Mobile Health: Revolutionizing
Healthcare Through Transdisciplinary Research. IEEE Computer (2013) 46
(1):28–35. doi: 10.1109/MC.2012.392
39. Steinhubl SR, Muse ED, Topol EJ. The emerging field of mobile health. Sci
Transl Med (2015) 7(283):283rv3. doi: 10.1126/scitranslmed.aaa3487
40. Reichert M, Lutz A, Deuschle M, Gilles M, Hill H, Limberger MF, et al.
Improving motor activity assessment in depression: which sensor placement,
analytic strategy and diurnal time frame are most powerful in distinguishing
patients from controls and monitoring treatment effects. PloS One (2015) 10
(4):e0124231. doi: 10.1371/journal.pone.0124231
41. Nakamura T, Takumi T, Takano A, Aoyagi N, Yoshiuchi K, Struzik ZR, et al.
Of mice and men–universality and breakdown of behavioral organization.
PloS One (2008) 3(4):e2050. doi: 10.1371/journal.pone.0002050
42. Wehr TA, Wirz-Justice A, Goodwin FK, Duncan W, Gillin JC. Phase advance
of the circadian sleep-wake cycle as an antidepressant. Sci (New York NY)
(1979) 206(4419):710–3. doi: 10.1126/science.227056
43. Bouhuys AL, Beersma DG, van den Hoofdakker RH. Observed behavior as a
predictor of the response to sleep deprivation in depressed patients. Psychiatry
Res (1989) 28(1):47–61. doi: 10.1016/0165-1781(89)90197-2
44. Benedetti F, Dallaspezia S, Fulgosi MC, Barbini B, Colombo C, Smeraldi E.
Phase advance is an actimetric correlate of antidepressant response to sleep
deprivation and light therapy in bipolar depression. Chronobiol Int (2007) 24
(5):921–37. doi: 10.1080/07420520701649455
45. Bruckner TU, Wiegand MH. Motor activity in depressed patients during
therapeutic sleep deprivation. Eur Psychiatry (2010) 25(8):465–7. doi:
10.1016/j.eurpsy.2009.11.004
46. Trautmann N, Foo JC, Frank J, Witt SH, Streit F, Treutlein J, et al. Response to
therapeutic sleep deprivation: a naturalistic study of clinical and genetic factors
and post-treatment depressive symptom trajectory. Neuropsychopharmacology
(2018) 43:2572–7. doi: 10.1101/179457
47. Guy W. ECDEU Assessment Manual for Psychopharmacology - revised. Rockville,
MD, U.S.: U.S. Department of Health, Education, and Welfare, Public Health
Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH
Psychopharmacology Research Branch, Division of Extramural Research
Programs (1976).
48. Aitken RC. Measurement of feelings using visual analogue scales. Proc R Soc
Med (1969) 62(10):989–93. doi: 10.1177/003591576906201005
49. Singer JD, Willett JB. Applied longitudinal data analysis: Modeling change and
event occurrence. New York, NY, US: Oxford University Press (2003).
50. Souetre E, Salvati E, Belugou JL, Pringuey D, Candito M, Krebs B, et al.
Circadian rhythms in depression and recovery: evidence for blunted
amplitude as the main chronobiological abnormality. Psychiatry Res (1989)
28(3):263–78. doi: 10.1016/0165-1781(89)90207-2
51. Razavi N, Horn H, Koschorke P, Hugli S, Hofle O, Muller T, et al. Measuring
motor activity in major depression: the association between the Hamilton
Depression Rating Scale and actigraphy. Psychiatry Res (2011) 190(2-3):212–
6. doi: 10.1016/j.psychres.2011.05.028
52. Baune BT, Caliskan S, Todder D. Effects of adjunctive antidepressant therapy
with quetiapine on clinical outcome, quality of sleep and daytime motor activity
in patients with treatment-resistant depression. Hum Psychopharmacol (2007)
22(1):1–9. doi: 10.1002/hup.817
53. Todder D, Caliskan S, Baune BT. Longitudinal changes of day-time and night-time
grossmotor activity in clinical responders and non-responders ofmajor depression.
World J Biol Psychia (2009) 10(4):276–84. doi: 10.3109/15622970701403081
54. Raoux N, Benoit O, Dantchev N, Denise P, Franc B, Allilaire JF, et al. Circadian
pattern of motor activity in major depressed patients undergoing antidepressant
therapy: relationship between actigraphic measures and clinical course. Psychiatry
Res (1994) 52(1):85–98. doi: 10.1016/0165-1781(94)90122-8
55. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to
change. Br J Psychiatry (1979) 134:382–9. doi: 10.1192/bjp.134.4.382July 2020 | Volume 11 | Article 688
Foo et al. Movement in Sleep Deprivation Treatment56. Beck AT, Steer RA, Brown GK. Manual for Beck depression inventory-II. 2nd
ed edition. San Antonio: Harcourt Brace (1996).
57. Stanley N. Actigraphy in human psychopharmacology: a review. Hum
Psychopharmacol (2003) 18(1):39–49. doi: 10.1002/hup.471
58. Gorny SW, Spiro JR. Comparing different methodologies used in wrist
actigraphy. Sleep Rev (2001) 40–2.
59. Blackwell T, Redline S, Ancoli-Israel S, Schneider JL, Surovec S, JohnsonNL, et al.
Comparison of sleep parameters from actigraphy and polysomnography in older
women: the SOF study. Sleep (2008) 31(2):283–91. doi: 10.1093/sleep/31.2.283
60. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. The
role of actigraphy in the study of sleep and circadian rhythms. Sleep (2003) 26
(3):342–92. doi: 10.1093/sleep/26.3.342
61. Riemann D, Wiegand M, Lauer CJ, Berger M. Naps after total sleep
deprivation in depressed patients: are they depressiogenic? Psychiatry Res
(1993) 49(2):109–20. doi: 10.1016/0165-1781(93)90099-3
62. Trull TJ, Ebner-Priemer U. Ambulatory assessment. Ann Rev Clin Psych
(2013) 9:151–76. doi: 10.1146/annurev-clinpsy-050212-185510
63. Trull TJ, Ebner-Priemer UW. Using experience sampling methods/ecological
momentary assessment (ESM/EMA) in clinical assessment and clinicalFrontiers in Psychiatry | www.frontiersin.org 9research: introduction to the special section. Psychol Assess (2009) 21
(4):457–62. doi: 10.1037/a0017653
Conflict of Interest: AM-L has received consultant fees from Boehringer
Ingelheim, Brainsway, Elsevier, Lundbeck Int. Neuroscience Foundation and
Science Advances.
The remaining authors declare that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
Copyright © 2020 Foo, Sirignano, Trautmann, Kim, Witt, Streit, Frank, Zillich,
Meyer-Lindenberg, Ebner-Priemer, Schilling, Schredl, Yamamoto, Gilles, Deuschle
and Rietschel. This is an open-access article distributed under the terms of the Creative
Commons Attribution License (CC BY). The use, distribution or reproduction in other
forums is permitted, provided the original author(s) and the copyright owner(s) are
credited and that the original publication in this journal is cited, in accordance with
accepted academic practice. No use, distribution or reproduction is permitted which
does not comply with these terms.July 2020 | Volume 11 | Article 688
